Supha Pharmachem Ltd operates in Trading & Distributors within the Industrials sector.
585 historical price candles were omitted because the exchange source has not been verified.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Standalone figures
| Ratio | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin % | — | — | — | 2.5% | 1.3% | 3.1% | 1% | 2.9% |
| EBITDA margin % | -8.6% | — | 13.5% | 0.8% | 0.3% | 1.5% | 0.8% | -0.8% |
| EBIT margin % | -8.6% | — | 13.1% | 0.7% | 0.3% | 1.4% | 0.8% | -0.8% |
| PAT margin % | 0% | — | 9.7% | 0.5% | 0.2% | 1.1% | 0.8% | 0.7% |
| Working capital | ||||||||
| Receivable days | — | — | — | 96 | 46 | 123 | 83 | 969 |
| Inventory days | — | — | — | 13 | 61 | 5 | 12 | 455 |
| Payable days | — | — | — | 99 | 91 | 62 | 65 | 542 |
| NWC days | — | — | — | 10 | 16 | 67 | 30 | 882 |
| Leverage | ||||||||
| Current ratio | — | — | — | 1.59 | 1.02 | 1.01 | 1.02 | 1.03 |
| Debt to EBITDA | — | — | — | 14.79 | 0 | 0 | 1.73 | — |
| Debt to equity | — | — | — | 2.72 | 0 | 0 | 1.34 | 26.36 |
| Interest coverage | — | — | — | — | 14.8 | -91.5 | 14 | 1.7 |
| Asset turnover | — | — | — | 2.34 | 2.26 | 0.44 | 2.07 | 0.14 |
| Return ratios | ||||||||
| Return on assets % | — | — | — | 1.2% | 0.5% | 0.5% | 1.7% | 0.1% |
| Return on capital employed % | — | — | — | 4.6% | 16.9% | 95.7% | 203.8% | 20.8% |
| Return on equity % | — | — | — | 12.4% | 21.9% | 52.4% | 76.2% | 3.5% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
No scheme among the 32 fund houses on record reported a position in Supha Pharmachem Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
| Holder (%) | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.11% | 1.11% | 1.11% | 1.11% | 1.11% | 1.11% | 1.11% | 1.11% | 1.11% | 1.13% | 1.13% | 1.13% | |
| 0% | 0.04% | 0.08% | 0.04% | 0.04% | 0% | 0% | 0% | 0% | 0% | 0% | 1.7% | |
| DII | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 98.89% | 98.85% | 98.81% | 98.85% | 98.85% | 98.89% | 98.89% | 98.89% | 98.89% | 98.87% | 98.87% | 97.17% | |
| No. of shareholders | — | — | — | — | — | — | — | — | — | — | 1,14,119 | 1,11,269 |
Promoter holding up 0.02 percentage points since Mar 2023.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 17 Jun 2026 | PRAKASH ANAND GUPTA | Bulk | BSE | Sell | 65,10,419 | ₹0.27 | ₹0.18 Cr |
| 7 Apr 2026 | RG TRADERS | Bulk | BSE | Sell | 44,55,537 | ₹0.34 | ₹0.15 Cr |
| 30 Mar 2026 | RG TRADERS | Bulk | BSE | Buy | 74,02,096 | ₹0.32 | ₹0.24 Cr |
| 30 Mar 2026 | AAKASHHITESHBHAIZINZUVADIA | Bulk | BSE | Sell | 56,85,000 | ₹0.32 | ₹0.18 Cr |
| 18 Mar 2026 | L7 HITECH PRIVATE LIMITED | Bulk | BSE | Sell | 76,37,750 | ₹0.39 | ₹0.30 Cr |
| 12 Mar 2026 | SHARE INDIA SECURITIES LIMITED | Bulk | BSE | Buy | 93,66,874 | ₹0.47 | ₹0.44 Cr |
| 12 Mar 2026 | SHARE INDIA SECURITIES LIMITED | Bulk | BSE | Sell | 90,64,010 | ₹0.46 | ₹0.42 Cr |
| 12 Mar 2026 | JASMITSINGHCHANDHOK | Bulk | BSE | Buy | 72,00,000 | ₹0.47 | ₹0.34 Cr |
| 12 Mar 2026 | ISHAAN TRADEFIN LLP | Bulk | BSE | Sell | 59,39,000 | ₹0.46 | ₹0.27 Cr |
| 12 Mar 2026 | ISHAAN TRADEFIN LLP | Bulk | BSE | Buy | 9,39,000 | ₹0.45 | ₹0.04 Cr |
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding The Order Passed By Hon'Ble National Company Law Appellate Tribunal (NCLAT) Principal Bench, New Delhi
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
Documents link to external sources (exchange filings, company investor pages).
Closure of Trading Window
Intimation Of Change In Insolvency Professional - Appointment Of Resolution Professional (RP) In Place Of Interim Resolution Professional (IRP)
Post- Coc Update
Corporate Insolvency Resolution Process (CIRP)-List of Creditors
Postponement Of Board Meeting Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Closure of Trading Window
Intimation Of Receipt Of Order From National Company Law Tribunal (NCLT)
| Date | Category | Subject | Filing |
|---|---|---|---|
| 30 Jun 2026, 3:53 pm | Company Update General | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding The Order Passed By Hon'Ble National Company Law Appellate Tribunal (NCLAT) Principal Bench, New Delhi | |
| 27 Jun 2026, 3:51 pm | Insider Trading / SAST Closure of Trading Window | Closure of Trading Window | |
| 12 May 2026, 3:08 pm | Company Update General | Intimation Of Change In Insolvency Professional - Appointment Of Resolution Professional (RP) In Place Of Interim Resolution Professional (IRP) | |
| 17 Apr 2026, 9:49 pm | Company Update General | Post- Coc Update | |
| 10 Apr 2026, 6:55 pm | Company Update List of Creditors | Corporate Insolvency Resolution Process (CIRP)-List of Creditors | |
| 2 Apr 2026, 6:19 pm | Company Update General | Postponement Of Board Meeting Under Regulation 30 Of SEBI (LODR) Regulations, 2015 | |
| 25 Mar 2026, 12:08 pm | Insider Trading / SAST Closure of Trading Window | Closure of Trading Window | |
| 21 Mar 2026, 6:00 pm | Company Update General | Intimation Of Receipt Of Order From National Company Law Tribunal (NCLT) |
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Redington LimitedREDINGTONREDINGTON | ₹31,112 Cr | ₹33,749 Cr | ₹1,28,133 Cr | ₹2,537 Cr | 1.9% | ₹1,701 Cr | 1.1% | 21.7% | 15.8% | 34 |
| Mmtc LimitedMMTCMMTC | ₹8,444 Cr | ₹8,444 Cr | ₹3 Cr | ₹-179 Cr | — | ₹447 Cr | — | -0.5% | 20.3% | -2,38,864 |
| Mstc LimitedMSTCLTDMSTCLTD | ₹4,969 Cr | ₹5,114 Cr | ₹386 Cr | ₹236 Cr | 60.6% | ₹234 Cr | 59.1% | 34.9% | 26.6% | -92 |
| Bn Agrochem LimitedBNAGROCHEMBNAGROCHEM | ₹2,228 Cr | ₹2,310 Cr | ₹299 Cr | ₹-37 Cr | -12.5% | ₹20 Cr | 6.6% | 12% | 8.5% | 130 |
| Creative Newtech LimitedCNLCNL | ₹1,619 Cr | ₹1,943 Cr | ₹2,783 Cr | ₹99 Cr | 3.2% | ₹74 Cr | 2.6% | 29.2% | 21.4% | 75 |
| Pervasive Commodities LtdPERVASIVEPERVASIVE | ₹1,090 Cr | ₹1,090 Cr | ₹43 Cr | ₹-0 Cr | -1.1% | ₹-0 Cr | -0.1% | 0% | -0.1% | 548 |
| RRP Defense LtdRRPDEFENSERRPDEFENSE | ₹842 Cr | ₹844 Cr | ₹12 Cr | ₹-1 Cr | -8.4% | ₹-1 Cr | -8.2% | -13.7% | -13.7% | -15 |
| The Yamuna Syndicate LtdYSLYSL | ₹779 Cr | ₹779 Cr | ₹69 Cr | ₹2 Cr | 2.2% | ₹52 Cr | 75.3% | 0.3% | 4% | 60 |
| The State Trading Corporation Of India LimitedSTCINDIASTCINDIA | ₹636 Cr | ₹1,811 Cr | ₹0 Cr | ₹-46 Cr | — | ₹21 Cr | — | — | — | — |
| SMT Engineering LtdSMTELSMTEL | ₹598 Cr | ₹679 Cr | ₹162 Cr | ₹41 Cr | 25% | ₹23 Cr | 14.2% | 33.2% | 25.2% | 395 |
| Bijoy Hans LtdARVAYAARVAYA | ₹576 Cr | ₹579 Cr | ₹0 Cr | ₹-1 Cr | — | ₹0 Cr | — | -3.9% | -3.9% | — |
| Riddhi Siddhi Gluco Biols LtdRIDDHIRIDDHI | ₹505 Cr | ₹787 Cr | ₹236 Cr | ₹-12 Cr | -5.2% | ₹61 Cr | -5.2% | 2.8% | -0.8% | 65 |
| ₹ Cr | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 0 | — | 3 | 90 | 505 | 510 | 4,042 | 223 | |
| COGS | — | -0 | — | -2 | 88 | 498 | 494 | 4,001 | 216 |
| Gross profit | — | — | — | — | 2 | 6 | 16 | 40 | 6 |
| 1 | 1 | — | 4 | 2 | 5 | 9 | 7 | 8 | |
| Operating profit (EBITDA) | -0 | -0 | — | 0 | 1 | 2 | 7 | 33 | -2 |
| OPM % | -5.2% | -8.6% | — | 13.5% | 0.8% | 0.3% | 1.5% | 0.8% | -0.8% |
| Depreciation | — | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | — | — | — | — | 0 | 0 | -0 | 4 | 5 |
| — | — | — | — | 0 | 0 | 0 | 21 | 11 | |
| Profit before tax | — | 0 | 0 | 0 | 1 | 2 | 7 | 50 | 4 |
| Tax | — | — | — | — | 0 | 0 | 2 | 18 | 2 |
| Tax % | — | — | — | — | 26.2% | 29.4% | 26.6% | 35.1% | 58.2% |
| 0 | 0 | 0 | 0 | 0 | 1 | 5 | 33 | 2 | |
| PAT margin % | 0% | 0% | — | 9.7% | 0.5% | 0.2% | 1.1% | 0.8% | 0.7% |
| EPS (₹) | — | — | — | — | 1.3 | 3 | 15.1 | 3.3 | 0 |
| EPS adjusted (₹) | — | — | — | 0 | 0 | 0 | 0.1 | 0.8 | 0 |
| Annual report | Annual report for Mar 2017 | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 |
| ₹ Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Equity capital | 4 | 4 | 4 | 4 | 10 | 40 |
| Reserves | — | 0 | 1 | 7 | 33 | 3 |
| — | 11 | 0 | 0 | 58 | 1,141 | |
| — | 24 | 219 | 1,144 | 1,847 | 355 | |
| Total equity & liabilities | — | 39 | 224 | 1,154 | 1,948 | 1,540 |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| CWIP | — | — | — | — | — | — |
| Investments | — | 0 | 0 | 0 | 0 | 0 |
| — | 38 | 224 | 1,154 | 1,948 | 1,540 | |
| Total assets | — | 39 | 224 | 1,154 | 1,948 | 1,540 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| -10 | 11 | 21 | -74 | -1,079 | |
| -0 | -0 | -0 | 0 | 0 | |
| 10 | -11 | -0 | 54 | 1,078 | |
| Net cash flow | -0 | 1 | 20 | -20 | -0 |
| Free cash flow | — | — | — | — | — |
| CFO / Operating profit % | — | 663.5% | 274.4% | -222.6% | — |